AbbVie’s earnings exhibit reports 2021 Lupron revenue of $604 million in the United States and $179 million internationally, totaling $783 million. This is product-wide revenue and the latest separately located annual Lupron figure in this run, not current annual revenue.
Lupron 604 179 783
AbbVie’s earnings exhibit reports 2021 Lupron revenue of $604 million in the United States and $179 million internationally, totaling $783 million. This is product-wide revenue and the latest separately located annual Lupron figure in this run, not current annual revenue. AbbVie’s FY2022 earnings exhibit and 10-K were also checked; no separate 2022 Lupron annual sales figure was located.